Eris Lifesciences Limited (NSE: ERIS) stock falls 5% intraday to ₹1352.0, breaking below support in a significant breakdown.
Syngene International Limited (SYNGENE) drops 8% intraday to ₹380.1, breaking below support. This breakdown is backed by Q1 FY27 results showing revenue at R.
Jagsonpal Pharmaceuticals Ltd reports Q1 FY27 results with revenue up 9% and PAT up 22%, maintaining robust cash reserves at ₹1,700 Mn.
Syngene International Limited (SYNGENE) reports Q1 FY27 revenue at Rs. 736 Cr, with Operating EBITDA at Rs. 91 Cr.
Hikal Limited (NSE: HIKAL) earns EcoVadis Gold Medal, ranking in top 5% globally for sustainability performance.
Concord Biotech Limited (NSE: CONCORDBIO) stock extends gains, moving up 5% intraday to ₹1331.0, despite the 6M trendline status being CONSOLIDATING UP.
Gland Pharma Limited (GLAND) receives USFDA approval for Sugammadex Injection 200 mg/2 mL, expanding its injectable portfolio.
RPG Life Sciences Limited (RPGLIFE) reports 15.8% revenue growth in Q1 FY27, with EBITDA margin expanding to 24.5%.
Alembic Pharmaceuticals Limited (APLLTD) secures USFDA final approval for Prucalopride Tablets, 1 mg and 2 mg, expanding its generic drug portfolio.
Fabtech Technologies Limited (FABTECH) reports a 10.3% revenue increase in Q1 FY2026-2027, with a record contribution margin of 46.7%.